Prevalence and implications of hyponatremia in patients undergoing transcatheter aortic valve replacement

Read full text Summarise with VIRAT
Authors: Brett David Cohen, S Singh, Luke Miller, Nicholas Roma, Spandan Desai, Michael Durkin
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Hyponatremia is linked to worse outcomes in cardiac patients, but its impact in transcatheter aortic valve replacement (TAVR) remains unclear. We examined the prevalence, predictors, and outcomes of hyponatremia among TAVR patients using the National Inpatient Sample (NIS). Methods The NIS was queried to identify 369,190 hospitalizations for TAVR, stratified by hyponatremia status. Survey weighted logistic regressions estimated associations between hyponatremia and in-hospital mortality and disability as identified by discharge disposition. Predictors of hyponatremia were assessed using survey weighted multivariable logistic regression. Both were adjusted for demographics, comorbidities, and hospital characteristics. Results Hyponatremia was present in 4.1% (n=15,060) of TAVR admissions. Independent predictors of hyponatremia included higher Charlson comorbidity scores (OR 2.88, 2.29–3.61), female sex (OR 1.15, 1.06–1.25), and atrial fibrillation (OR 1.35, 1.25–1.46). Patients with hyponatremia had significantly higher crude mortality (3.9% vs 1.0%; p

Fields of Study & Subjects

Electrolyte and hormonal disorders Cardiac Valve Diseases and Treatments Aortic Disease and Treatment Approaches

Publication details

Journal / source
European Heart Journal Supplements
Volume
28
Issue
Supplement_3
Pages
suag056.134
Publication date
1 March 2026
Language
EN